Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001044321-11-000173
Filing Date
2011-08-09
Accepted
2011-08-09 14:53:46
Documents
1
Group Members
AUSTIN W. MARXEAWM INVESTMENT COMPANY, INC.DAVID M. GREENHOUSELS ADVISERS, LLCMG ADVISERS, LLCMGP ADVISERS LIMITED PARTNERSHIPSPECIAL SITUATIONS CAYMAN FUND, L.P.SPECIAL SITUATIONS FUND III QP, L.P.SPECIAL SITUATIONS LIFE SCIENCE FUND, L.P.SPECIAL SITUATI

Document Format Files

Seq Description Document Type Size
1 CYCLACEL PHARM 13G/A cycc13gt3.txt SC 13G/A 9628
  Complete submission text file 0001044321-11-000173.txt   11731
Mailing Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022
Business Address C/O SPECIAL SITUATIONS FUNDS 527 MADISON AVENUE, SUITE 2600 NEW YORK NY 10022 2122076500
MARXE AUSTIN W & GREENHOUSE DAVID M (Filed by) CIK: 0001044321 (see all company filings)

EIN.: 000000000
Type: SC 13G/A

Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Subject) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80136 | Film No.: 111020376
SIC: 2834 Pharmaceutical Preparations